NCT02020668UnknownPhase 2
Phase II Study of Physiotherapy in Rheumatoid Arthritis: Randomized Single Blind Wait-list Controlled Trial
Macmillan Research Group UK1 site in 1 country82 target enrollmentStarted: May 1, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Sponsor
- Enrollment
- 82
- Locations
- 1
- Primary Endpoint
- Pain
Study Overview
Brief Summary
Despite leading cause of morbidity, treatment strategies for Rheumatic diseases are geared almost exclusively toward medical-pharmacological area away from offering the patient the possibility of an interdisciplinary approach to their disease.
Present study test whether treatment of physiotherapy reduces stiffness and pain inherent in rheumatic disease and improve their quality of life related to health.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients older than 18 years
- •History of Rheumatoid Arthritis (RA) symptoms for less than 7 years
- •Had RA by American College of Rheumatology (ACR) criteria
- •ACR functional RA class I, II or III
- •Hemoglobin more than 8g/dL without evidence of active bleeding
- •Positive for rheumatoid factor (RF) or anti cyclic citrullinated protein
- •standard conventional medicine were allowed within the approved dosage regimen
Exclusion Criteria
- •connective tissue disease
- •any other alternative or complementary medicine with in last 3 months.
- •corticosteroid, disease modifying medicines
- •Poorly controlled diabetes, hypertension, hepatitis, cardiac disease, liver diseases, carcinoma, drug abuse
Outcomes
Primary Outcomes
Pain
Time Frame: Change from baseline in Numerical Scale Downie at 16 weeks
Secondary Outcomes
- Quality of Life(Change from Baseline in Short Form (SF) 36 at 16 weeks)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Phase 2
Lovastatin for the Treatment of Mildly Active Rheumatoid ArthritisRheumatoid ArthritisNCT00302952National Institute of Allergy and Infectious Diseases (NIAID)64
Completed
Not Applicable
BeSt, BehandelStrategieën in Reumatoïde Artritis.NL-OMON24149Dutch College of Health Insurance Companies508
Completed
Phase 3
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid ArthritisRheumatoid ArthritisNCT05814627AbbVie487
Completed
Not Applicable
Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid ArthritisRheumatoid ArthritisNCT02288520Nordic Pharma SAS854
Completed
Not Applicable
A Physiotherapist Led Intervention to Promote Physical Activity in Rheumatoid Arthritis - a Pilot StudyRheumatoid ArthritisNCT03644160University of Limerick58